IDiyas

For the Inventor, By the Inventor

Rockville, MD, United States of America

Xin Wei Wang

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 50(Granted Patents)


Location History:

  • North Potomac, MD (US) (1999 - 2008)
  • Lilburn, GA (US) (2017 - 2020)
  • Liburn, GA (US) (2020)
  • Rockville, MD (US) (2003 - 2022)

Company Filing History:

goldMedal19 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
silverMedal3 out of 827 
 
The Ohio State University
 patents
bronzeMedal2 out of 207 
 
Fudan University
 patents
4. 1 out of 1,215 
 
The United States of America As Represented by the Department of Health
 patents
5. 1 out of 2,202 
 
The United States of America As Represented by the Secretary of
 patents
where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...
Loading Chart...
21 patents (USPTO):
1. 11306362 - Gene signature predictive of hepatocellular carcinoma response to transcatheter arterial chemoembolization (TACE) (2022-04-19),
2. 10683558 - Selective detection of (2020-06-16),
3. 10669591 - Selective detection of (2020-06-02),
4. 9593385 - [object Object] (2017-03-14),
5. 9464324 - Methods of determining the prognosis of an adenocarcinoma (2016-10-11),
6. 9394358 - Gene signature for predicting prognosis of patients with solid tumors (2016-07-19),
7. 9125923 - Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy (2015-09-08),
8. 8735082 - Gene signature for predicting prognosis of patients with solid tumors (2014-05-27),
9. 8568977 - Compositions and methods for diagnosis and treatment of tumors (2013-10-29),
10. 8465917 - Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells (2013-06-18),
11. 8252538 - MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma (2012-08-28),
12. 8247183 - Compositions and methods for diagnosis and treatment of tumors (2012-08-21),
13. 7803380 - Compositions and methods for diagnosis and treatment of tumors (2010-09-28),
14. 7438892 - Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity (2008-10-21),
15. 7338807 - Screening assays for compounds that cause apoptosis (2008-03-04),

Title: The Innovative Journey of Xin Wei Wang

Introduction: Xin Wei Wang, a pioneering inventor based in Rockville, MD (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Xin Wei Wang holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Xin Wei Wang has demonstrated a remarkable ability to translate cutting-edge ideas into tangible inventions that have the potential to revolutionize industries.

Collaborations: Xin Wei Wang has collaborated with leading research institutions, universities, and companies to further his innovative pursuits, fostering a culture of creativity and excellence in the field of inventions.

Conclusion: Xin Wei Wang's relentless passion for innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventions. His impact on the technological landscape is profound and enduring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…